Cited by

• Randomized Trial of Fixed-Dose Capecitabine Compared With Standard-Dose Capecitabine in Metastatic Breast Cancer: X-7/7 Trial.

  Khan QJ, Bohnenkamp C, Monson TE, Phadnis MA, Clark L, Smith HE, Raja V, Elia M, O'Dea A, Fesen MR, Crane GJ, Nye LE, Baranda JC, Pluenneke RE, Hoffmann M, Al-Rajabi RMT, Kasi A, McKittrick RJ, Mitchell L, LaFaver S, Sharma P. Khan QJ, et al. JCO Oncol Adv. 2025 Jan 30;2(1):e2400068. doi: 10.1200/OA-24-00068. eCollection 2025. JCO Oncol Adv. 2025. PMID: 39917581 Free PMC article.
• Secondary Endpoint Utilization and Publication Rate among Phase III Oncology Trials.

  Beck EJ, Sherry AD, Florez MA, Kouzy R, Abi Jaoude J, Lin TA, Miller AM, Passy AH, Kupferman GS, Patel RR, Chino F, Higbie VS, Parseghian CM, Overman MJ, Minsky BD, Thomas CR Jr, Tang C, Msaouel P, Ludmir EB. Beck EJ, et al. Cancer Res Commun. 2024 Aug 1;4(8):2183-2188. doi: 10.1158/2767-9764.CRC-24-0265. Cancer Res Commun. 2024. PMID: 39099199 Free PMC article.
• Overall Survival and Quality-of-Life Superiority in Modern Phase 3 Oncology Trials: A Meta-Epidemiological Analysis.

  Sherry AD, Miller AM, Parlapalli JP, Kupferman GS, Beck EJ, McDonald J, Kouzy R, Abi Jaoude J, Lin TA, Sanford NN, Chino F, Gyawali B, Booth C, Msaouel P, Ludmir EB. Sherry AD, et al. JAMA Oncol. 2025 Jul 1;11(7):718-724. doi: 10.1001/jamaoncol.2025.1002. JAMA Oncol. 2025. PMID: 40451185
• Carboplatin plus Paclitaxel in Combination with the Histone Deacetylate Inhibitor, Vorinostat, in Patients with Recurrent Platinum-Sensitive Ovarian Cancer.

  Meteran H, Knudsen AØ, Jørgensen TL, Nielsen D, Herrstedt J. Meteran H, et al. J Clin Med. 2024 Feb 3;13(3):897. doi: 10.3390/jcm13030897. J Clin Med. 2024. PMID: 38337591 Free PMC article.
• Activity of CDK4/6 inhibitors and parameters affecting survival in elderly patients in age-subgroups: Turkish Oncology Group (TOG) retrospective study.

  Kahraman S, Hizal M, Demirel BC, Guven DC, Gumusay O, Uluc BO, Bayram E, Gulbagci B, Yasar A, Davarci SE, Mocan EE, Acar O, Isik D, Aydin E, Karakas Y, Ozcelik M, Keser M, Okutur SK, Eren O, Menekse S, Aydin D, Yilmaz F, Dogan O, Ozkanli G, Yucel H, Sunar V, Aykan MB, Ozdemir O, Duman BB, Keskinkilic M, Sakalar T, Inal A, Karaoglanoglu M, Aksoy A, Er MM, Turhal NS, Kalkan NO, Sendur MAN. Kahraman S, et al. BMC Cancer. 2024 Dec 30;24(1):1592. doi: 10.1186/s12885-024-13357-5. BMC Cancer. 2024. PMID: 39736618 Free PMC article.